section name header

Information

AHFS Class:

40:12 Replacement Preparations


Generic Name

Products

Potassium chloride is available as a 2-mEq/mL concentrate for injection in 5-, 10-, 15, and 20-mL single-dose, preservative-free vials.3858 Each mL of the concentrate contains 149 mg of potassium chloride (2 mEq of potassium) in water for injection; hydrochloric acid may have been added for pH adjustment.3858 The concentrate must be diluted prior to administration.3858 Ensure complete mixing of the concentrate with the infusion solution, particularly if soft or bag type containers are used.3858

Potassium chloride also is available as a premixed, ready-to-use infusion solution in single-dose flexible plastic bags containing 10 or 20 mEq potassium in 50 or 100 mL, and 40 mEq potassium in 100 mL.3859 The premixed solutions have the following properties:3859

Potassium Ion
Concentration
/Container Size
Potassium
Chloride
Concentration
OsmolarityPotassium
(and Chloride) Ion
Concentration
10 mEq/100 mL7.46 g/L200 mOsm/L100 mEq/L
10 mEq/50 mL14.9 g/L400 mOsm/L200 mEq/L
20 mEq/100 mL14.9 g/L400 mOsm/L200 mEq/L
20 mEq/50 mL29.8 g/L799 mOsm/L400 mEq/L
40 mEq/100 mL29.8 g/L799 mOsm/L400 mEq/L

pH

From 4 to 8.3858; 3859

Osmolarity

The 2-mEq/mL concentrate for injection has a calculated osmolarity of approximately 4000 mOsm/L.3858

Osmolality

The osmolality of potassium chloride (Abbott) 2 mEq/mL was determined to be 4355 mOsm/kg by freezing-point depression and 3440 mOsm/kg by vapor pressure.1071

The osmolality of a potassium chloride 7.5% solution was determined to be 1895 mOsm/kg.1233

Administration

Potassium chloride is administered by slow intravenous infusion, preferably through a central venous line to reduce the risk of extravasation, pain, and phlebitis associated with peripheral infusion.3858; 3859 Care must be taken to avoid paravenous administration or extravasation because such administration may result in tissue damage.3859 Concentrations of 400 mEq/L must be administered through a central venous line.3859

The concentrate must be diluted prior to administration; direct intravenous injection of undiluted potassium chloride concentrate may result in fatal cardiac arrhythmia and cardiac arrest.3858

Great care is required when adding potassium chloride to infusion solutions, whether in flexible plastic containers or in rigid bottles. Adding potassium chloride to running infusion solutions hanging in the use position, especially in flexible containers, has resulted in the pooling of potassium chloride and a resultant high-concentration bolus of the drug being administered to patients, with serious and even fatal consequences. Attempts to mix adequately the potassium chloride in flexible containers by squeezing the container in the hanging position were unsuccessful. It is recommended that drugs be admixed with solutions in flexible containers when positioned with the injection arm of the container uppermost. With both rigid bottles and flexible containers, subsequent repeated inversion and agitation to effect thorough mixture are necessary.85; 130; 454; 455; 456; 714; 715; 1127; 1778; 2151

Stability

Intact containers of the concentrate for injection and premixed solution should be stored at controlled room temperature.3858; 3859 Unused portions of single-dose vials should be discarded.3858

Potassium chloride injection 80 mEq/L added to dextrose 5% contained in glass bottles results in a leaching of precipitates consisting of silica and alumina.129

Compatibility

Solution Compatibility

Additive Compatibility

Drugs in Syringe Compatibility

Y-Site Injection Compatibility (1:1 Mixture)

Additional Compatibility Information

Methylprednisolone

The compatibility of methylprednisolone sodium succinate (Upjohn) with potassium chloride added to an auxiliary medication infusion unit has been studied. Primary admixtures were prepared by adding potassium chloride 40 mEq/L to dextrose 5%, dextrose 5% in sodium chloride 0.9%, and Ringer’s injection, lactated. The primary admixture was added along with methylprednisolone sodium succinate (Upjohn) to the auxiliary medication infusion unit with the following results:329

Methylprednisolone
Sodium Succinate
Potassium Chloride
40 mEq/L
Primary Solution
Results
500 mgD5S, D5W, LR qs 100 mLClear solution for 24 hr
1000 mgD5W qs 100 mLClear solution for 24 hr
1000 mgD5S, LR qs 100 mLClear solution for 6 hr
2000 mgD5S, D5W, LR qs 100 mLClear solution for 24 hr

Other Info

References

For a list of references cited in the text of this monograph, search the monograph titled References.

Copyrights

ASHP® Injectable Drug InformationTM. Selected Revisions September 12, 2024. © Copyright, 2024. American Society of Health-System Pharmacists®, 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.